Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 67 publications
Nilotinib in chronic myeloid leukemia: clinical value, real-world challenges, and the potential of nilotinib tablets to improve therapeutic outcomes.
Journal: Expert review of hematology
Published: August 12, 2026
A plain language summary of how the body processes a lower-dose nilotinib tablet (Danziten™) compared to the existing capsule (Tasigna®).
Journal: Future oncology (London, England)
Published: February 06, 2026
Optimizing Asparaginase Treatment for Adolescent and Young Adult (AYA) Patients With Acute Lymphoblastic Leukemia: US Consensus Panel Recommendations.
Journal: American journal of hematology
Published: July 17, 2025
Recognition, prevention, and management of adverse events associated with asparaginase/ pegaspargase treatment of acute lymphoblastic leukemia in adults: consensus of an expert panel.
Journal: Haematologica
Published: December 14, 2024
Pharmacokinetic profile of novel reduced-dose Danziten™ (nilotinib tablets) versus Tasigna® (nilotinib capsules): in vivo bioequivalence and population pharmacokinetic analysis.
Journal: Cancer chemotherapy and pharmacology
Published: November 15, 2024
Delaying pegaspargase during induction in adults with acute lymphoblastic leukaemia is associated with lower risk of high-grade hepatotoxicity without adversely impacting outcomes.
Journal: British journal of haematology
Published: August 06, 2024
Correction: Shorter long-term post-transplant life expectancy may be due to prior chemotherapy for the underlying disease: analysis of 3012 patients with acute myeloid leukemia enrolled on 9 consecutive ECOG-ACRIN trials.
Journal: Bone marrow transplantation
Published: July 18, 2024
Shorter long-term post-transplant life expectancy may be due to prior chemotherapy for the underlying disease: analysis of 3012 patients with acute myeloid leukemia enrolled on 9 consecutive ECOG-ACRIN trials.
Journal: Bone marrow transplantation
Published: August 07, 2023
Asparaginase: How to Better Manage Toxicities in Adults.
Journal: Current oncology reports
Published: September 19, 2022
SOHO State of the Art Updates and Next Questions | Asparaginase-Understanding and Overcoming Toxicities in Adults with ALL.
Journal: Clinical lymphoma, myeloma & leukemia
Published: July 20, 2022
Treatment of Patients with Acute Myeloid Leukemia with the Targeted Alpha-Particle Nanogenerator Actinium-225-Lintuzumab.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: October 19, 2021
Last Updated: 09/26/2026